Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Southern Cross Electrical lands three data centre projects with Amazon, Microsoft and NEXTDC
    • News

    Southern Cross Electrical lands three data centre projects with Amazon, Microsoft and NEXTDC

    Heyday is enjoying its heyday, signing on tech giants as clients once again. In a significant development, electrical engineering company Southern Cross Electrical Engineering (ASX: SXE) subsidiary, Heyday—an electrical installation service, has been awarded three prestigious data centre projects in Sydney. Collectively, they are valued at over $60 million.  The projects are poised to reinforce

    Read More
    Public
  • Chimeric’s cell therapy drug moves on to Phase 1B trial to treat malignant brain cancer
    • News

    Chimeric’s cell therapy drug moves on to Phase 1B trial to treat malignant brain cancer

    In 2020, the Department of Health and Aged Care revealed that approximately 2,000 Australians were diagnosed with brain cancer. New cases of brain cancer are increasing every year and Glioblastoma, the most common, complex, treatment-resistant, and deadliest type of brain cancer, accounts for 45% of all malignant brain tumours. On a global scale, it is

    Read More
    Public
  • Starpharma gains regulatory approval in Malaysia for nasal spray to build momentum in Asia
    • News

    Starpharma gains regulatory approval in Malaysia for nasal spray to build momentum in Asia

    Biopharmaceutical company Starpharma (ASX: SPL) has received regulatory approval for its antiviral nasal spray product, VIRALEZE, in Malaysia. This milestone achievement grants Starpharma and its commercial partners the opportunity to market and sell the innovative product in Malaysia, a country with a population exceeding 33 million.  VIRALEZE has garnered significant recognition in Asia following successful

    Read More
    Public
  • Doctor Care Anywhere sells GP2U to focus on UK growth
    • News

    Doctor Care Anywhere sells GP2U to focus on UK growth

    As it departs from Australia to cement its base in the UK alone, telehealth company Doctor Care Anywhere Group (ASX: DOC) has decided to sell its Aussie subsidiary GP2U Telehealth. The Company had bought GP2U for $11 million in September 2021 to tap into the mental health market in Australia, which worsened following the pandemic.

    Read More
    Public
  • Strong start to the week expected ahead of key RBA decision
    • Market Update

    Strong start to the week expected ahead of key RBA decision

    Australian Markets The XJO is expected to edge lower this morning following a similar night in the U.S. Coupled with their green futures, we are getting early indications that the bleeding has been stemmed for now – providing a much-needed breath of relief from the past few sessions of pain. Yesterday we tried our best

    Read More
    Public
  • Debt deal optimism, tech buying, XJO to rise
    • Market Update

    Debt deal optimism, tech buying, XJO to rise

    Australian Markets The XJO is expected to rally on open this morning following a strong recovery in the U.S last night. Their futures have also edged into the green which at least indicates that their strong buying isn’t being immediately met with profit taking. However, they stalled at key resistance last night, so we need

    Read More
    Public
  • «
  • ‹
  • 234
  • 235
  • 236
  • 237
  • 238
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.